IP Library Granted Patent US 9,918,951
Granted Patent B2
US 9,918,951 · App. 12/866,001 · Granted Mar 20, 2018

Method for improving storage stability of glutathione

Inventors: Yasushi Sakai (Tsukuba, JP); Shun Kayahashi (Tsukuba, JP)
Assignee: KYOWA HAKKO BIO CO., LTD.
A61K31/198A23L33/10A23L33/175A61K9/145A61K47/12A61K47/183A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,918,951
App. No.
12/866,001
Granted
Mar 20, 2018
Kind
B2
Abstract

The invention provides a method of improving the preservation stability of glutathione in a solid composition containing glutathione and arginine. In particular, glutathione and arginine are made to be coexistent with an organic acid such as citric acid, tartaric acid, ascorbic acid, malic acid, malonic acid, succinic acid, fumaric acid, maleic acid and the like. The amount of the organic acid to coexistent with glutathione and arginine is generally 0.1-2 parts by weight relative to 1 part by weight of arginine.

Claims (18)

1. A method of improving preservation stability of glutathione in a solid composition containing glutathione and arginine, which comprises achieving coexistence of glutathione and arginine, with an organic acid, in a solid composition containing 1 part by weight glutathione and 10-20 parts by weight of arginine relative to glutathione,

wherein

the organic acid is selected from the group consisting of citric acid, tartaric acid, and malic acid, and

the organic acid is present in an amount of 0.4-0.8 parts by weight of organic acid relative to 1 part by weight of arginine.

2. The method according to claim 1 , wherein the solid composition is a solid preparation.

3. The method according to claim 1 , wherein the organic acid is citric acid.

4. A solid composition comprising glutathione, arginine, and citric acid or tartaric acid,

wherein the composition comprises

10-20 parts by weight of arginine relative to 1 part by weight of glutathione, and

0.4-0.8 parts by weight citric acid or tartaric acid relative to 1 part by weight of arginine.

5. A solid preparation comprising glutathione, arginine, and citric acid or tartaric acid,

wherein the preparation comprises

10-20 parts by weight of arginine relative to 1 part by weight of glutathione, and

0.4-0.8 parts by weight citric acid or tartaric acid relative to 1 part by weight of arginine.

6. The method according to claim 2 , wherein the organic acid is citric acid.

7. The method according to claim 1 , wherein the organic acid is present in an amount of 4-24 parts by weight of organic acid relative to 1 part by weight of glutathione.

8. The method according to claim 1 , wherein the organic acid is tartaric acid.

9. The method according to claim 2 , wherein the organic acid is tartaric acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2010
From: SAKAI, YASUSHI; KAYAHASHI, SHUN
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 024782/0652 →
Priority Claims (1)
JP 2008-024855 · Feb 5, 2008 · national
Continuity (1)
Related Publication 20100311837A1 · Dec 9, 2010